[Clinical study on effect of kang' aibao oral liquid in treating 103 malignant tumor patients].
OBJECTIVE
To observe the clinical efficacy of Kangaibao oral liquid(KABOL), a Chinese herbal preparation in treating malignant turmor of middle or advanced stage.


METHODS
A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison.


RESULTS
The immunologic function, short-term effective rate (complete relieved rate and partial relieved rate), survival quality, 1-, 2- and 3-year survival rate, median suvival time, and the CEA declining rate of the KABOL group were significantly higher than those of the control group.


CONCLUSIONS
KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality of survival of tumor patient.
D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000401:mortality; D015996:Survival Rate